126 related articles for article (PubMed ID: 219988)
1. Clinical trial with testosterone undecanoate for male fertility control.
Nieschlag E; Hoogen H; Bölk M; Schuster H; Wickings EJ
Contraception; 1978 Dec; 18(6):607-14. PubMed ID: 219988
[TBL] [Abstract][Full Text] [Related]
2. Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats.
Zhang XW; Zhang C; Zhang W; Yang D; Meng S; Wang P; Guo J; Liu DH
Asian J Androl; 2016; 18(5):791-7. PubMed ID: 26459781
[TBL] [Abstract][Full Text] [Related]
3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
4. Trial of high-dose testosterone undecanoate in treatment of male infertility.
Kloer H; Hoogen H; Nieschlag E
Int J Androl; 1980 Apr; 3(2):121-9. PubMed ID: 6773890
[TBL] [Abstract][Full Text] [Related]
5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
[TBL] [Abstract][Full Text] [Related]
7. Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa.
Wang C; Leung A; Superlano L; Steiner B; Swerdloff RS
Fertil Steril; 1997 Jul; 68(1):149-53. PubMed ID: 9207601
[TBL] [Abstract][Full Text] [Related]
8. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
[TBL] [Abstract][Full Text] [Related]
10. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the use of testosterone oenanthate as a male contraceptive agent.
Mauss J; Börsch G; Richter E; Bormacher K
Contraception; 1974 Sep; 10(3):281-9. PubMed ID: 4374338
[TBL] [Abstract][Full Text] [Related]
12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
13. An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.
Meriggiola MC; Bremner WJ; Costantino A; Pavani A; Capelli M; Flamigni C
Fertil Steril; 1997 Nov; 68(5):844-50. PubMed ID: 9389813
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
15. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
16. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
[TBL] [Abstract][Full Text] [Related]
17. Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men.
Yang ZJ; Ye WS; Cui GH; Guo Y; Xue SP
Contraception; 2004 Sep; 70(3):203-11. PubMed ID: 15325889
[TBL] [Abstract][Full Text] [Related]
18. Treatment of idiopathic infertility with testosterone undecanoate. A double blind study.
Gregoriou O; Papadias C; Gargaropoulos A; Konidaris S; Kontogeorgi Z; Kalampokas E
Clin Exp Obstet Gynecol; 1993; 20(1):9-12. PubMed ID: 8462190
[TBL] [Abstract][Full Text] [Related]
19. Restoration of spermatogenesis and fertility in azoospermic mutant mice by suppression and reelevation of testosterone followed by intracytoplasmic sperm injection.
Tohda A; Okuno T; Matsumiya K; Okabe M; Kishikawa H; Dohmae K; Okuyama A; Nishimune Y
Biol Reprod; 2002 Jan; 66(1):85-90. PubMed ID: 11751268
[TBL] [Abstract][Full Text] [Related]
20. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.
Kinniburgh D; Zhu H; Cheng L; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2002 Jun; 17(6):1490-501. PubMed ID: 12042267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
